ARCA Other Operating Expenses from 2010 to 2024
| ABIO Stock | USD 3.45 0.05 1.47% |
Other Operating Expenses | First Reported 1997-03-31 | Previous Quarter 1.9 M | Current Value 1.6 M | Quarterly Volatility 9.5 M |
Check ARCA Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ARCA main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.5 K, Interest Expense of 637.9 K or Selling General Administrative of 7.2 M, as well as many exotic indicators such as Price To Sales Ratio of 0.26, Dividend Yield of 0.0 or PTB Ratio of 0.63. ARCA financial statements analysis is a perfect complement when working with ARCA Biopharma Valuation or Volatility modules.
ARCA | Other Operating Expenses |
Latest ARCA Biopharma's Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of ARCA Biopharma over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of ARCA Biopharma. It is also known as ARCA Biopharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. ARCA Biopharma's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ARCA Biopharma's overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
ARCA Other Operating Expenses Regression Statistics
| Arithmetic Mean | 9,889,947 | |
| Geometric Mean | 8,971,692 | |
| Coefficient Of Variation | 48.10 | |
| Mean Deviation | 3,634,836 | |
| Median | 8,118,000 | |
| Standard Deviation | 4,756,708 | |
| Sample Variance | 22.6T | |
| Range | 15M | |
| R-Value | 0.24 | |
| Mean Square Error | 23T | |
| R-Squared | 0.06 | |
| Significance | 0.39 | |
| Slope | 256,198 | |
| Total Sum of Squares | 316.8T |
ARCA Other Operating Expenses History
About ARCA Biopharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ARCA Biopharma income statement, its balance sheet, and the statement of cash flows. ARCA Biopharma investors use historical funamental indicators, such as ARCA Biopharma's Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although ARCA Biopharma investors may use each financial statement separately, they are all related. The changes in ARCA Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ARCA Biopharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ARCA Biopharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ARCA Biopharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 7.3 M | 6.9 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ARCA Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ARCA Biopharma's short interest history, or implied volatility extrapolated from ARCA Biopharma options trading.
Pair Trading with ARCA Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ARCA Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARCA Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving together with ARCA Stock
| 0.69 | ELYM | Eliem Therapeutics | PairCorr |
Moving against ARCA Stock
| 0.86 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.76 | MGTX | MeiraGTx Holdings PLC Financial Report 9th of May 2024 | PairCorr |
| 0.72 | ALKS | Alkermes Plc Financial Report 24th of April 2024 | PairCorr |
| 0.7 | PCRX | Pacira Pharmaceuticals Financial Report 1st of May 2024 | PairCorr |
| 0.69 | PFE | Pfizer Inc Aggressive Push | PairCorr |
The ability to find closely correlated positions to ARCA Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ARCA Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ARCA Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ARCA Biopharma to buy it.
The correlation of ARCA Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ARCA Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ARCA Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ARCA Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of ARCA Biopharma Correlation against competitors. To learn how to invest in ARCA Stock, please use our How to Invest in ARCA Biopharma guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for ARCA Stock analysis
When running ARCA Biopharma's price analysis, check to measure ARCA Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARCA Biopharma is operating at the current time. Most of ARCA Biopharma's value examination focuses on studying past and present price action to predict the probability of ARCA Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ARCA Biopharma's price. Additionally, you may evaluate how the addition of ARCA Biopharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is ARCA Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ARCA Biopharma. If investors know ARCA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ARCA Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Return On Assets (0.11) | Return On Equity (0.14) |
The market value of ARCA Biopharma is measured differently than its book value, which is the value of ARCA that is recorded on the company's balance sheet. Investors also form their own opinion of ARCA Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ARCA Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARCA Biopharma's market value can be influenced by many factors that don't directly affect ARCA Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARCA Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARCA Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARCA Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.